PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35303923-0	2022	Oral administration of Lactobacillus brevis 23017 combined with ellagic acid attenuates intestinal inflammatory injury caused by Eimeria infection by activating the Nrf2/HO-1 antioxidant pathway.	Ellagic Acid	64-76	heme oxygenase 1	Gallus gallus	170-174	
35303923-1	2022	The aim of this study was to investigate whether oral administration of Lactobacillus brevis 23017 (LB) alone and in combination with ellagic acid inhibits ChTLR15/ChNLRP3/ChIL-1beta by activating the Nrf2/HO-1 pathway to attenuate intestinal inflammatory injury.	Ellagic Acid	134-146	heme oxygenase 1	Gallus gallus	206-210